Home › Ablexis Announces Perpetual License Of The AlivaMab Mouse To A Top 15 Pharma
 

Keywords :   


Ablexis Announces Perpetual License Of The AlivaMab Mouse To A Top 15 Pharma

2016-03-30 06:12:05| drugdiscoveryonline Home Page

2, 2016 – Ablexis, LLC announced recently the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company

Tags: top license mouse announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Who is Paula Vennells? Ex-Post Office boss in Horizon IT inquiry
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
16.05Dow and SCGC Partner to Change 200KTA of Plastic Waste Into Circular Products
16.05Leanpath Uses Generative AI to Drive Action on Food Waste Data
16.05AkzoNobels Como Site Achieves Highest Automotive Industry Quality Certification
16.05ECONWARDs Counterplan for Landfill-Bound Organics
16.05Mortgage rates cut but borrowing pressures remain
16.05Coca-Cola Completes Transition to 100% Recycled Plastic for Bottles in Canada
More »